申请人:The Research Foundation of State University of New York
公开号:US08329741B2
公开(公告)日:2012-12-11
Provided herein are substituted pyrrolidines that demonstrate binding at biogenic amine transporters and can be synthesized by a methodology based on a chiral dirhodium catalyst. Compositions comprising substituted pyrrolidines can be used to treat central nervous system disorders such as schizophrenia.
本文提供的是通过手性二铑催化剂合成的替代吡咯烷衍生物,其在生物胺转运体上表现出结合作用。含有替代吡咯烷的组合物可用于治疗中枢神经系统疾病,如精神分裂症。